Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.

Peyrot M, Rubin RR.

Diabetes Technol Ther. 2009 Jan;11(1):57-62. doi: 10.1089/dia.2008.0002.

PMID:
19132857
2.

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.

Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.

Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170. Review.

3.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
4.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
5.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
6.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
7.

Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness [Internet].

Golden SH, Brown T, Yeh HC, Maruthur N, Ranasinghe P, Berger Z, Suh Y, Wilson LM, Haberl EB, Bass EB.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jul.

8.

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.

Pickup JC, Renard E.

Diabetes Care. 2008 Feb;31 Suppl 2:S140-5. doi: 10.2337/dc08-s235. Review.

PMID:
18227475
9.

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Joubert M, Reznik Y.

Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28. Review.

PMID:
22209014
10.

Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.

Wojciechowski P, Ryś P, Lipowska A, Gawęska M, Małecki MT.

Pol Arch Med Wewn. 2011 Oct;121(10):333-43. Review.

11.

Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials.

Szypowska A, Ramotowska A, Dzygalo K, Golicki D.

Eur J Endocrinol. 2012 Apr;166(4):567-74. doi: 10.1530/EJE-11-0642. Epub 2011 Nov 17. Review.

12.

Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.

Polsky S, Giordano D, Voelmle MK, Garcetti R, Garg SK.

Postgrad Med. 2016 May;128(4):418-26. doi: 10.1080/00325481.2016.1159910. Epub 2016 Mar 23. Review.

PMID:
26924774
13.

Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.

Rodbard D.

Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S3-S13. doi: 10.1089/dia.2015.0417. Review.

14.

CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.

Fonseca VA, Grunberger G, Anhalt H, Bailey TS, Blevins T, Garg SK, Handelsman Y, Hirsch IB, Orzeck EA, Roberts VL, Tamborlane W; Consensus Conference Writing Committee.

Endocr Pract. 2016 Aug;22(8):1008-21. doi: 10.4158/EP161392.CS. Epub 2016 May 23.

PMID:
27214060
15.

The use of continuous glucose monitoring in patients with type 2 diabetes.

Meade LT.

Diabetes Technol Ther. 2012 Feb;14(2):190-5. doi: 10.1089/dia.2011.0086. Epub 2011 Sep 20. Review.

PMID:
21933000
17.

Insulin Delivery and Glucose Monitoring Methods: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 57 [Internet].

Yeh HC, Lau BD, Golden SH, Donner T, Brown TT, Bass EB.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Mar.

18.

The evidence base for diabetes technology: appropriate and inappropriate meta-analysis.

Pickup JC.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1567-74. Review.

19.

Vascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic Variability.

Joseph JI, Torjman MC, Strasma PJ.

J Diabetes Sci Technol. 2015 Jul;9(4):725-38. doi: 10.1177/1932296815587938. Epub 2015 Jun 15. Review.

20.

Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials.

Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, Coyle C, Goalen M, Murad MS, Erwin PJ, Corpus J, Montori VM, Murad MH.

J Diabetes Sci Technol. 2011 Jul 1;5(4):952-65. Review.

Supplemental Content

Support Center